| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |